- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18:30 | IBP Q4 2025 slides: record margins fuel earnings beat, diversification pays off | ||
| 18:30 | Donaldson Q2 FY26 slides: $820M Facet deal amid earnings miss | ||
| 18:30 | Stella-Jones Q4 2025 slides: infrastructure push amid railway headwinds | ||
| 18:30 | JPMorgan cuts WEG stock rating on earnings miss, currency impact | ||
| 18:06 | Deutsche Telekom FY 2025 slides: strong beat, 10% EPS growth targeted | ||
| 18:06 | CRA International FY2025 slides: 9% growth, strong margins, AI opportunity | ||
| 18:06 | Tecnoglass FY 2025 slides: record revenue hit by margin pressures | ||
| 18:06 | Service Properties Q4 2025 slides: $859M asset sales fuel deleveraging | ||
| 18:06 | UMH Properties Feb 2026 slides: strong annual growth masks Q4 challenges | ||
| 18:06 | TriMas Q4 2025 slides: aerospace sale proceeds fuel transformation | ||
| 18:06 | Fiera Capital Q4 2025 slides: margins expand despite revenue miss | ||
| 18:06 | Ingevity Q4 2025 slides: strong cash flow masks revenue headwinds | ||
| 18:06 | LSB Q4/FY'25 slides: operational gains drive 42% EBITDA surge | ||
| 18:06 | TD Cowen reiterates Buy rating on C4 Therapeutics stock | ||
| 18:06 | Leerink cuts Mirum Pharmaceuticals stock price target to $118 | ||
| 18:06 | Raymond James reiterates Acadia Healthcare stock rating at Outperform | ||
| 18:06 | Needham reiterates Hold on Warner Brothers Discovery stock | ||
| 18:06 | UBS reiterates Neutral on Penumbra stock, keeps $374 target | ||
| 18:06 | Stifel reiterates Buy rating on Kymera Therapeutics stock at $114 | ||
| 18:06 | Evercore ISI reiterates Mirum Pharmaceuticals stock rating at Outperform | ||
| 18:06 | Magnite stock price target lowered to $30 by Benchmark on CTV shift | ||
| 18:06 | UBS cuts Boston Beer stock price target on weaker sales outlook | ||
| 18:06 | UBS raises Keurig Dr Pepper stock price target on deal accretion | ||
| 17:18 | Intelbras Q4 2025 slides: margins expand despite revenue decline | ||
| 17:18 | DIRTT Q4 2025 slides: ambitious guidance targets 250% EBITDA jump |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.